Publicacions en què col·labora amb Joaquín Cubiella Fernández (13)

2023

  1. Serum DNA methylome of the colorectal cancer serrated pathway enables non-invasive detection

    Molecular Oncology

  2. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas

    Clinical Epigenetics, Vol. 15, Núm. 1

  3. Targeted depletion of pks+ bacteria from a fecal microbiota using specific antibodies

    mSystems, Vol. 8, Núm. 3, pp. e0007923

2022

  1. Comparative analysis of capture methods for genomic profiling of circulating tumor cells in colorectal cancer

    Genomics, Vol. 114, Núm. 6

  2. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

  3. Real-time polyp detection model using convolutional neural networks

    Neural Computing and Applications, Vol. 34, Núm. 13, pp. 10375-10396

2021

  1. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method

    Expert Review of Anticancer Therapy, Vol. 21, Núm. 7, pp. 723-738

  2. Deep Neural Networks approaches for detecting and classifying colorectal polyps

    Neurocomputing, Vol. 423, pp. 721-734

2020

  1. Value of serum NEUROG1 methylation for the detection of advanced adenomas and colorectal cancer

    Diagnostics, Vol. 10, Núm. 7

2018

  1. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples

    Clinical Epigenetics, Vol. 10, Núm. 1

2016

  1. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer

    Scientific Reports, Vol. 6

2015

  1. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening

    Scientific Reports, Vol. 5

  2. Serum sCD26 for colorectal cancer screening in family-risk individuals: Comparison with faecal immunochemical test

    British Journal of Cancer, Vol. 112, Núm. 2, pp. 375-381